These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31630241)

  • 21. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.
    Truong DD; Gollomp SM; Jankovic J; LeWitt PA; Marx M; Hanschmann A; Fernandez HH;
    J Neural Transm (Vienna); 2013 Sep; 120(9):1345-53. PubMed ID: 23435927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II.
    Kent R; Robertson A; Quiñones Aguilar S; Tzoulis C; Maltman J
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
    Hassell TJW; Charles D
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32331272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Laryngeal dystonia--personal experience with botulin toxin treatment].
    Domzał TM; Tomczykiewicz K
    Neurol Neurochir Pol; 2002; 36(1):173-9. PubMed ID: 12053608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological study in Meige's syndrome with predominant blepharospasm.
    Ransmayr G; Kleedorfer B; Dierckx RA; Poewe W; Kemmler GW; Gerstenbrand F
    Clin Neuropharmacol; 1988 Feb; 11(1):68-76. PubMed ID: 3280128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facial muscle spasms: an Australian study.
    Kowal L; Davies R; Kiely PM
    Aust N Z J Ophthalmol; 1998 May; 26(2):123-8. PubMed ID: 9630292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of treatment with botulinum toxin on neurogenic blepharospasm.
    Elston JS; Russell RW
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1857-9. PubMed ID: 3924284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.
    Elston JS
    Br J Ophthalmol; 1987 Sep; 71(9):664-8. PubMed ID: 3663559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years.
    Streitová H; Bareš M
    Acta Neurol Belg; 2014 Dec; 114(4):285-91. PubMed ID: 24604684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam in Meige's syndrome.
    Yardimci N; Karatas M; Kilinc M; Benli S
    Acta Neurol Scand; 2006 Jul; 114(1):63-6. PubMed ID: 16774630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm.
    Nüssgens Z; Roggenkämper P
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):197-9. PubMed ID: 9143885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switchover study of onabotulinumtoxinA to incobotulinumtoxinA for facial dystonia.
    Bladen JC; Favor M; Litwin A; Malhotra R
    Clin Exp Ophthalmol; 2020 Dec; 48(9):1146-1151. PubMed ID: 32710447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of blepharospasm with botulinum toxin].
    Pikielny RT; Micheli FE; Fernández Pardal MM; Casas Parera I; Giannaula RJ; Gatto M
    Medicina (B Aires); 1990; 50(2):129-34. PubMed ID: 2101846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oromandibular dystonia and botulinum toxins].
    Van Durme B; Loeb I; Van Reck J
    Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?
    Pang AL; O'Day J
    Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.